We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
25 hedge funds and large institutions have $11.3M invested in Evelo Biosciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
27% less capital invested
Capital invested by funds: $15.5M → $11.3M (-$4.19M)
36% less funds holding
Funds holding: 39 → 25 (-14)
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
93% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 15
Holders
25
Holders Change
-14
Holders Change %
-35.9%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
8
Reduced
13
Closed
15
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$27K
Top Buyers
| 1 |
Barclays
London,
United Kingdom
|
+$275K |
| 2 |
Morgan Stanley
New York
|
+$8.25K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.06K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$3.03K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$395 |
